Exchange: NASDAQ·Updated 04:10 PM EST
BBNX logo

BBNX Beta Bionics Inc.

$14.33
$0.39
(2.65%)
Today
Closed $14.33
$0.00
(0.00%)
After Hours
Reported EarningsOct 27
Mkt Cap$800.28M
Vol1.37M

About BBNX

Beta Bionics, Inc. is a commercial-stage medical device company. It engages in the design, development, and commercialization of solutions for insulin-requiring people with diabetes. The company was founded by Edward R. Damiano on October 21, 2015 and is headquartered in Irvine, CA.
49

Neutral Sentiment

How do you feel about BBNX?

healthcareguru
$BBNX Going to be one of the best new product stories of 2027 in MedTech…buy every dip here. Headed to $30+. 🔥🦾 $DXCM $PODD $IHI $XLV
2
StocktwitsEarnings
$BBNX Q3 '26 Earnings Results & Recap • Reported GAAP EPS of -$0.52 down -57.58% YoY • Reported revenue of $35.51M up 30.31% YoY • Beta Bionics estimates FY2026 total revenue of approximately $124M to $126M, gross margin of 58.5% to 59.5%, and 37% to 39% of new patient starts reimbursed through PBP.
1
shoc24
$BBNX reports earnings today after the close. I’m bullish heading into the report: BBNX has beaten EPS estimates in 6 of its last 8 reports, according to Stock Meadow. Analysts expect EPS of −$0.52. What are you watching for?
1
sailstock
$BBNX the new Eversense 365 and iLet integration, what happens if an implanted sensor fails before the year is up? Does the patient contact Senseonics or Beta Bionics, who provides the replacement sensor, and how quickly can a trained provider remove and replace it? Also, is the replacement covered, and what does the iLet do while the patient is waiting?

Advertisement|Remove ads.